Proton Pump Inhibitors - CME Conferences
Proton Pump Inhibitors - CME Conferences
Proton Pump Inhibitors - CME Conferences
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
6 th Annual Primary Care Spring Conference Thursday, April 12, 2012<br />
Lipid Lowering Therapy<br />
• The current and anticipated updated NCEP-ATP-<br />
IV guidelines recommend using a full dose of an<br />
evidence based high potency statin which has<br />
been demonstrated to reduce clinical CV events<br />
before adding a second lipid altering agent<br />
• Are we treating to reduce events or just to achieve<br />
goal lipid levels?<br />
• LDL is primary goal (< 70mg% or < 100mg%)<br />
• Non-HDL is secondary goal (30 mg% above LDL<br />
goal)<br />
• New AHA/ACC triglyceride goals (optimal<br />
Change language